Reactions Weekly

, Volume 1658, Issue 1, pp 147–147 | Cite as

Crizotinib

Development of resistance: case report
Case report

Reference

  1. Du J, et al. Circulating tumor DNA profiling by next generation sequencing reveals heterogeneity of crizotinib resistance mechanisms in a gastric cancer patient with MET amplification. Oncotarget 8: 26281-26287, No. 16, 2017. Available from: URL: http://doi.org/10.18632/oncotarget.15457 - China

Copyright information

© Springer International Publishing AG 2017

Personalised recommendations